Pharmacology of Carbonic Anhydrase Inhibitors
I. Introduction and Class Overview Carbonic anhydrase inhibitors (CAIs) are a class of drugs that reversibly inhibit the enzyme carbonic anhydrase, thereby interfering with HCO₃⁻ (bicarbonate) reabsorption and decreasing hydrogen ion secretion in several tissues. Their major clinical uses are as diuretics, in the management of glaucoma, acute mountain sickness, certain epilepsies, and as adjuncts … Read more